9th May 2018 12:35
LONDON (Alliance News) - Healthcare-focused advisory firm Cello Health PLC said on Wednesday at its annual general meeting that it has had a strong start to 2018 and expects this to continue.
Cello said that, in the three months to March, revenue and profit growth from its Insight and Consulting businesses was good, as was performance from its Communications business in the US.
Cello, which was called Cello Group PLC until late April, also said its Signal business has begun the year well following a restructuring in the US in 2017.
Its balance sheet remains "strong", with cash conversion promising so far this year and it is continuing to evaluate potential acquisitions.
The company also announced Non-Executive Directors Paul Hamilton and Will David are both to retire "during" 2018, and it has begun a search process for replacements.
Shares were up 1.7% on Wednesday at 121.50 pence each.
Related Shares:
CLL.L